Skip to content
News
University of Montana researchers working toward COVID-19 vaccine
April 24, 2020/
Researchers at the University of Montana are working to develop a COVID-19 vaccine with the help of a $2.5 million grant from the National Institutes of Health.
The University of Montana has become a leader in vaccine development, ever since a team led by Jay Evans joined UM in 2016, after pharmaceutical giant GlaxoSmithKline downsized its operations in Hamilton, and the research team moved to Missoula.
Evans and his team at UM’s Center for Translational Medicine began working on the vaccine after being contacted by the NIH in February, prompting them to get to work on COVID-19 research while the federal grant process worked through the pipeline.
